-
1
-
-
45849092207
-
Potentiation and priming of platelet activation: A potential target for antiplatelet therapy
-
Gresele P, Falcinelli E, Momi S. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol Sci 2008; 29: 352–360.
-
(2008)
Trends Pharmacol Sci
, vol.29
, pp. 352-360
-
-
Gresele, P.1
Falcinelli, E.2
Momi, S.3
-
2
-
-
79960649902
-
Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke
-
Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011; Suppl 1: 92–104.
-
(2011)
J Thromb Haemost
, pp. 92-104
-
-
Nieswandt, B.1
Pleines, I.2
Bender, M.3
-
3
-
-
34250818668
-
Adhesion mechanisms in platelet function
-
Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100: 1673–1685.
-
(2007)
Circ Res
, vol.100
, pp. 1673-1685
-
-
Ruggeri, Z.M.1
Mendolicchio, G.L.2
-
4
-
-
84904663379
-
Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming
-
Blair TA, Moore SF, Williams CM, et al. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming. Arterioscler Thromb Vasc Biol 2014; 34: 1681–1688.
-
(2014)
Arterioscler Thromb Vasc Biol
, vol.34
, pp. 1681-1688
-
-
Blair, T.A.1
Moore, S.F.2
Williams, C.M.3
-
5
-
-
65849522315
-
Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation
-
Lupia E, Bosco O, Mariano F, et al. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemost 2009; 7: 1000–1008.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1000-1008
-
-
Lupia, E.1
Bosco, O.2
Mariano, F.3
-
6
-
-
0027340057
-
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C
-
Vezza R, Roberti R, Nenci GG, et al. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood 1993; 82: 2704–2713.
-
(1993)
Blood
, vol.82
, pp. 2704-2713
-
-
Vezza, R.1
Roberti, R.2
Nenci, G.G.3
-
7
-
-
0033031854
-
Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation
-
Wang JS, Cheng LJ. Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 1999; 19: 1559–1565.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 1559-1565
-
-
Wang, J.S.1
Cheng, L.J.2
-
8
-
-
70449711236
-
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
-
Momi S, Falcinelli E, Giannini S, et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009; 206: 2365–2379.
-
(2009)
J Exp Med
, vol.206
, pp. 2365-2379
-
-
Momi, S.1
Falcinelli, E.2
Giannini, S.3
-
10
-
-
84887014442
-
Platelets and matrix metalloproteinases
-
Seizer P, May AE. Platelets and matrix metalloproteinases. Thromb Haemost 2013; 110: 903–909.
-
(2013)
Thromb Haemost
, vol.110
, pp. 903-909
-
-
Seizer, P.1
May, A.E.2
-
11
-
-
76049125185
-
Matrix metalloproteinases and peripheral arterial disease
-
Busti C, Falcinelli E, Momi S, et al. Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 2010; 5: 13–25.
-
(2010)
Intern Emerg Med
, vol.5
, pp. 13-25
-
-
Busti, C.1
Falcinelli, E.2
Momi, S.3
-
12
-
-
39549104947
-
Matrix metalloproteinases in platelet function: Coming of age
-
Santos-Martinez MJ, Medina C, Gilmer JF, et al. Matrix metalloproteinases in platelet function: coming of age. J Thromb Haemost 2008; 6: 514–516.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 514-516
-
-
Santos-Martinez, M.J.1
Medina, C.2
Gilmer, J.F.3
-
13
-
-
0030946445
-
Release of gelatinase A during platelet activation mediates aggregation
-
Sawicki G, Salas E, Murat J, et al. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616–619.
-
(1997)
Nature
, vol.386
, pp. 616-619
-
-
Sawicki, G.1
Salas, E.2
Murat, J.3
-
14
-
-
64249129547
-
Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site
-
Trivedi V, Boire A, Tchernychev B, et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 2009; 137: 332–343.
-
(2009)
Cell
, vol.137
, pp. 332-343
-
-
Trivedi, V.1
Boire, A.2
Tchernychev, B.3
-
15
-
-
28444487916
-
Intraplatelet signalling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation
-
Falcinelli E, Guglielmini G, Torti M, et al. Intraplatelet signalling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005; 3: 2526–2535.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2526-2535
-
-
Falcinelli, E.1
Guglielmini, G.2
Torti, M.3
-
16
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
-
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827–839.
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
17
-
-
0034331185
-
Platelets release a trimolecular complex components MT-1– MMP/TIMP2/MMP2: Involvement in MMP2 activation and platelet aggregation
-
Kazes I, Elalamy I, Sraer JD, et al. Platelets release a trimolecular complex components MT-1– MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood 2000; 96: 3064–3069.
-
(2000)
Blood
, vol.96
, pp. 3064-3069
-
-
Kazes, I.1
Elalamy, I.2
Sraer, J.D.3
-
18
-
-
80051907306
-
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: A mechanism for regulating synthetic events
-
Cecchetti L, Tolley ND, Michetti N, et al. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood 2011; 18: 1903–1911.
-
(2011)
Blood
, vol.18
, pp. 1903-1911
-
-
Cecchetti, L.1
Tolley, N.D.2
Michetti, N.3
-
19
-
-
67349188767
-
Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: A novel organisation for these secreted proteins
-
Villeneuve J, Block A, Le Bousse-Kerdilès MC, et al. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organisation for these secreted proteins. Exp Hematol 2009; 37: 849–856.
-
(2009)
Exp Hematol
, vol.37
, pp. 849-856
-
-
Villeneuve, J.1
Block, A.2
Le Bousse-Kerdilès, M.C.3
-
20
-
-
34250817676
-
Platelets release active matrix metalloproteinase- 2 in vivo in humans at a site of vascular injury: Lack of inhibition by aspirin
-
Falcinelli E, Giannini S, Boschetti E, et al. Platelets release active matrix metalloproteinase- 2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin. Br J Haematol 2007; 138: 221–230.
-
(2007)
Br J Haematol
, vol.138
, pp. 221-230
-
-
Falcinelli, E.1
Giannini, S.2
Boschetti, E.3
-
21
-
-
79751508250
-
Platelets release matrix metalloproteinase- 2 in the coronary circulation of patients with acute coronary syndromes: Possible role in sustained platelet activation
-
Gresele P, Falcinelli E, Loffredo F, et al. Platelets release matrix metalloproteinase- 2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. Eur Heart J 2011; 32: 316–325.
-
(2011)
Eur Heart J
, vol.32
, pp. 316-325
-
-
Gresele, P.1
Falcinelli, E.2
Loffredo, F.3
-
22
-
-
84901952299
-
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events
-
Lenti M, Falcinelli E, Pompili M, et al. Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. Thromb Haemost 2014; 111: 1089–1101.
-
(2014)
Thromb Haemost
, vol.111
, pp. 1089-1101
-
-
Lenti, M.1
Falcinelli, E.2
Pompili, M.3
-
23
-
-
39549089084
-
MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta 3
-
Choi WS, Jeon OH, Kim HH, et al. MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta 3. J Thromb Haemost 2008; 6: 517–523.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 517-523
-
-
Choi, W.S.1
Jeon, O.H.2
Kim, H.H.3
-
24
-
-
84891887337
-
Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin
-
Soslau G, Mason C, Lynch S, et al. Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin. Thromb Haemost 2014; 111: 140–153.
-
(2014)
Thromb Haemost
, vol.111
, pp. 140-153
-
-
Soslau, G.1
Mason, C.2
Lynch, S.3
-
25
-
-
0034917958
-
Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: Interactions with nitric oxide
-
Martinez A, Salas E, Radomski A, et al. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Sci Monit 2001; 7: 646–651.
-
(2001)
Sci Monit
, vol.7
, pp. 646-651
-
-
Martinez, A.1
Salas, E.2
Radomski, A.3
-
26
-
-
0023574370
-
Shear stress activation of platelet glycoprotein IIb-IIIa plus VWF causes aggregation: Filter blockage and the long bleeding time in von Willebrand’s disease
-
O’Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb-IIIa plus VWF causes aggregation: filter blockage and the long bleeding time in von Willebrand’s disease. Blood 1987; 70: 1354–1361.
-
(1987)
Blood
, vol.70
, pp. 1354-1361
-
-
O’Brien, J.R.1
Salmon, G.P.2
-
27
-
-
0037454139
-
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
-
Gresele P, Guglielmini G, De Angelis M, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013–1020.
-
(2003)
J am Coll Cardiol
, vol.41
, pp. 1013-1020
-
-
Gresele, P.1
Guglielmini, G.2
De Angelis, M.3
-
28
-
-
77956090233
-
Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent
-
Gresele P, Marzotti S, Guglielmini G, et al. Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. Diabetes Care 2010; 33: 1262–1268.
-
(2010)
Diabetes Care
, vol.33
, pp. 1262-1268
-
-
Gresele, P.1
Marzotti, S.2
Guglielmini, G.3
-
29
-
-
0032534836
-
A new perfusion chamber to detect platelet adhesion using a small volume of blood
-
Sixma JJ, de Groot PG, van Zanten H, et al. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res 1998; 92: S43–46.
-
(1998)
Thromb Res
, vol.92
, pp. S43-S46
-
-
Sixma, J.J.1
De Groot, P.G.2
Van Zanten, H.3
-
30
-
-
34547828238
-
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties
-
Momi S, Impagnatiello F, Guzzetta M, et al. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol 2007; 570: 115–124.
-
(2007)
Eur J Pharmacol
, vol.570
, pp. 115-124
-
-
Momi, S.1
Impagnatiello, F.2
Guzzetta, M.3
-
31
-
-
28444491951
-
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression
-
Rossiello MR, Momi S, Caracchini R, et al. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. J Thromb Haemost 2005; 3: 2554–2562.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2554-2562
-
-
Rossiello, M.R.1
Momi, S.2
Caracchini, R.3
-
32
-
-
84897114562
-
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy
-
Tersteeg C, de Maat S, De Meyer SF, et al. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Circulation 2014; 129: 1320–1331.
-
(2014)
Circulation
, vol.129
, pp. 1320-1331
-
-
Tersteeg, C.1
De Maat, S.2
De Meyer, S.F.3
-
33
-
-
0038692324
-
Thrombopoietin increases platelet adhesion under flow and decreases rolling
-
Van Os E, Wu Y-P, Pouwels JG, et al. Thrombopoietin increases platelet adhesion under flow and decreases rolling. Br J Haematol 2003; 121: 482–490.
-
(2003)
Br J Haematol
, vol.121
, pp. 482-490
-
-
Van Os, E.1
Wu, Y.-P.2
Pouwels, J.G.3
-
34
-
-
3242724262
-
Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions
-
Goto S, Tamura N, Ishida H. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. J Am Coll Cardiol 2004 21; 44: 316–323.
-
(2004)
J am Coll Cardiol
, vol.21
, Issue.44
, pp. 316-323
-
-
Goto, S.1
Tamura, N.2
Ishida, H.3
-
35
-
-
84921629241
-
Visualisation of nitric oxide production by individual platelets during adhesion in flowing blood
-
Cozzi MR, Guglielmini G, Battiston M, et al. Visualisation of nitric oxide production by individual platelets during adhesion in flowing blood. Blood 2015; 125: 697–705.
-
(2015)
Blood
, vol.125
, pp. 697-705
-
-
Cozzi, M.R.1
Guglielmini, G.2
Battiston, M.3
-
36
-
-
79251547404
-
Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood
-
Mendolicchio GL, Zaloni D, Bacci M, et al. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost 2011; 9: 373–382.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 373-382
-
-
Mendolicchio, G.L.1
Zaloni, D.2
Bacci, M.3
-
37
-
-
0029588629
-
Decreased platelet function in aortic valve stenosis: High shear platelet activation then inactivation
-
O’Brien JR, Etherington MD, Brant J, et al. Decreased platelet function in aortic valve stenosis: high shear platelet activation then inactivation. Br Heart J 1995; 74: 641–644.
-
(1995)
Br Heart J
, vol.74
, pp. 641-644
-
-
O’Brien, J.R.1
Etherington, M.D.2
Brant, J.3
-
38
-
-
0032833343
-
Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress
-
Menegatti M, Cristalli G, Gallo L, et al. Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress. Haematologica 1999; 84: 721–725.
-
(1999)
Haematologica
, vol.84
, pp. 721-725
-
-
Menegatti, M.1
Cristalli, G.2
Gallo, L.3
-
39
-
-
0026766487
-
Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation
-
Chow TW, Hellums JD, Moake JL, et al. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1992; 80: 113–120.
-
(1992)
Blood
, vol.80
, pp. 113-120
-
-
Chow, T.W.1
Hellums, J.D.2
Moake, J.L.3
-
40
-
-
0020408496
-
Changes in surface-bound and exchangeable calcium during platelet activation
-
Brass LF, Shattil SJ. Changes in surface-bound and exchangeable calcium during platelet activation. J Biol Chem 1982; 257: 14000–14005.
-
(1982)
J Biol Chem
, vol.257
, pp. 14000-14005
-
-
Brass, L.F.1
Shattil, S.J.2
-
41
-
-
0023908222
-
Shear-induced platelet aggregation can be mediated by VWF released from platelets, as well as by exogenous large or unusually large VWF multimers, requires adenosine diphosphate, and is resistant to aspirin
-
Moake JL, Turner NA, Stathopoulos NA, et al. Shear-induced platelet aggregation can be mediated by VWF released from platelets, as well as by exogenous large or unusually large VWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366–1374.
-
(1988)
Blood
, vol.71
, pp. 1366-1374
-
-
Moake, J.L.1
Turner, N.A.2
Stathopoulos, N.A.3
-
42
-
-
0037841983
-
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischaemia-reperfusion injury
-
Schulze CJ, Wang W, Suarez-Pinzon WL, et al. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischaemia-reperfusion injury. Circulation 2003; 107: 2487–2492.
-
(2003)
Circulation
, vol.107
, pp. 2487-2492
-
-
Schulze, C.J.1
Wang, W.2
Suarez-Pinzon, W.L.3
-
46
-
-
0027203787
-
Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide
-
Saelman EU, Hese KM, Nieuwenhuis HK, et al. Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide. Arterioscler Thromb 1993; 13: 1164–1170.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1164-1170
-
-
Saelman, E.U.1
Hese, K.M.2
Nieuwenhuis, H.K.3
-
48
-
-
79960638351
-
Regulating thrombus growth and stability to achieve an optimal response to injury
-
Brass LF, Wannemacher KM, Ma P, et al. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost 2011; 9: 66–75.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 66-75
-
-
Brass, L.F.1
Wannemacher, K.M.2
Ma, P.3
-
49
-
-
33846240313
-
Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation
-
Maxwell MJ, Westein E, Nesbitt WS, et al. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood 2007; 109: 566–576.
-
(2007)
Blood
, vol.109
, pp. 566-576
-
-
Maxwell, M.J.1
Westein, E.2
Nesbitt, W.S.3
-
50
-
-
0035865519
-
Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function
-
Gear AR, Suttitanamongkol S, Viisoreanu D, et al. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 2001; 97: 937–945.
-
(2001)
Blood
, vol.97
, pp. 937-945
-
-
Gear, A.R.1
Suttitanamongkol, S.2
Viisoreanu, D.3
-
51
-
-
80051531008
-
High shear flow induces migration of adherent human platelets
-
Kraemer BF, Schmidt C, Urban B, et al. High shear flow induces migration of adherent human platelets. Platelets 2011; 22: 415–421.
-
(2011)
Platelets
, vol.22
, pp. 415-421
-
-
Kraemer, B.F.1
Schmidt, C.2
Urban, B.3
|